(Q39259434)

10 September 2017

title

Intrathecal midazolam as supplementary analgesia for chronic lumbar pain--15 years' experience (English)

1 reference

10 September 2017

0 references

1 reference

Jan Prochazka

1

1 reference

10 September 2017

Ales Hejcl

series ordinal

2

1 reference

10 September 2017

Lidmila Prochazkova

series ordinal

3

1 reference

10 September 2017

publication date

1 September 2011

1 reference

10 September 2017

1 reference

10 September 2017

volume

12

1 reference

10 September 2017

issue

9

1 reference

10 September 2017

page(s)

1309-1315

1 reference

Management of back pain in patients with previous back surgery

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intrathecal midazolam II: combination with intrathecal fentanyl for labor pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

21 January 2018

Intrathecal analgesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intrathecal drug therapy for chronic pain: from basic science to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intraspinal therapy for the treatment of chronic pain: a review of the literature between 1990 and 2005 and suggested protocol for its rational and safe use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

The effects of intrathecal midazolam on sympathetic nervous system reflexes in man--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

The effect of intrathecal midazolam on post-operative pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intrathecal midazolam added to bupivacaine improves the duration and quality of spinal anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Long-term intrathecal administration of midazolam and clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Midazolam improves postoperative epidural analgesia with continuous infusion of local anaesthetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Future directions for intrathecal pain management: a review and update from the interdisciplinary polyanalgesic consensus conference 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Preclinical work leading to the development of spinal analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Catheter-associated masses in patients receiving intrathecal analgesic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

The neurotoxicity of drugs given intrathecally (spinal)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Neurotoxicity with single dose intrathecal midazolam administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Intrathecal midazolam I: a cohort study investigating safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Current developments in intraspinal agents for cancer and noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

Severe neurological complications after central neuraxial blockades in Sweden 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

From the FDA: what's in a label? A guide for the anesthesia practitioner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01218.X

10.1111/J.1526-4637.2011.01218.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference